Seven in 10 DSM-5 panel members has financial ties to drug companies. March 13, 2012— -- Controversy continues to swell around the fifth edition of the Diagnostic and Statistical Manual of Mental ...
Publication of the final results of the field trials for the upcoming Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) has prompted renewed criticism from one of its most ...
This is the saddest moment in my 45-year career of studying, practicing, and teaching psychiatry. The Board of Trustees of the American Psychiatric Association has given its final approval to a deeply ...